Flexport Ventures contrbuited to a debt and equity round which will boost product development for the export finance startup.

Electric aircraft developer Heart Aerospace raised $35m from investors including Mesa Air and United, while several corporates are set to exit remote access software developer Openpath.

GV has contributed to two rounds for the gene-editing technology developer, which publicly launched yesterday with $315m of funding.

Novel TMT returned to help the third-party e-commerce operator, with more than 25 brands in its stable, hike its 2021 funding to $317m.

The Deutsche Telekom and Sonae-backed cybersecurity services provider was valued at $4.3bn in a series F round that took its overall funding to more than $500m.

Access Biotechnology helped the small molecule drug developer increase its total funding to over $300m in a round led by BVF Partners.

SoftBank’s Vision Fund 2 supplied series E funding for the application management platform developer, valuing it above $1bn.

Tigermed and WuXi Biologics took part in the biopharmaceutical company's series D round, which will accelerate the development of its immuno-oncology drug candidates.

Existing investor Agilent helped the biomedical analysis technology developer close a series C round that pushed its overall funding past $110m.

Lilly Asia Ventures co-led a series A round for ProfoundBio that will help it develop its novel technology and targeted cancer therapeutics.